Model with LVEF | Model with s’ | Model with LVLS | Model with MAPSE | Model with LV-LWFS | |
---|---|---|---|---|---|
LVEF aOR (CI) | 0.97 (0.93–1.01) p = 0.10 | – | – | – | – |
s´ aOR (CI) | – | 0.93(0.76–1.16) p = 0.53 | – | – | – |
LVLS aOR (CI) | – | – | 1.10 (0.98–1.24) p = 0.11 | – | – |
MAPSE aOR (CI) | – | – | – | 0.84 (0.70–0.99) p = 0.04 | – |
LV-LWFS aOR (CI) | – | – | – | – | 0.85 (0.73–0.99) p = 0.04 |
Age | 1.07 (1.03–1.11) p = 0.001 | 1.04 (0.99–1.09) p = 0.10 | 1.06 (1.01–1.10) p = 0.01 | 1.06 (1.01–1.10) p = 0.01 | 1.06 (1.01–1.10) p = 0.01 |
Cardiac disease† | 0.77 (0.31–1.91) p = 0.58 | 0.76 (0.26–2.23) p = 0.61 | 0.71 (0.25–1.98) p = 0.51 | 0.83 (0.32–2.13) p = 0.70 | 0.82 (0.32–2.11) p = 0.68 |
SOFA | 0.96 (0.83–1.10) p = 0.56 | 0.97 (0.82–1.15) p = 0.75 | 1.12 (0.95–1.33) p = 0.19 | 1.00 (0.86–1.16) p = 0.99 | 0.99 (0.86–1.15) p = 0.93 |
SAPS 3 | 1.02 (0.99–1.05) p = 0.30 | 1.00 (0.98–1.03) p = 0.81 | 1.01 (0.97–1.04) p = 0.67 | 1.03 (0.99–1.07) p = 0.20 | 1.03 (0.99–1.07) p = 0.16 |
Creatinine | 1.00 (1.00–1.01) p = 0.02 | 1.00 (1.00–1.01) p = 0.13 | 1.01 (1.00–1.01) p = 0.02 | 1.00 (1.00–1.01) p = 0.02 | 1.00 (1.00–1.01) p = 0.02 |
RV systolic dysfunction‡ | 1.34 (0.54–3.33) p = 0.53 | 1.42 (0.43–4.66) p = 0.56 | 1.45 (0.51–4.10) p = 0.49 | 1.03 (0.39–2.75) p = 0.96 | 1.08 (0.41–2.81) p = 0.88 |